Since FMD could be affected by various clinical factors and medication use for diabetes, hypertension, or dyslipidemia [27,28], multiple regression analyses were performed in order to identify the impact of plasma leptin on FMD while controlling for important confounders in all, lean and overweight subjects, as described in the Statistical analysis section (Table 3). This evidence concerns the gene LEP and diabetes mellitus.